Chemiluminescent probe compound and application thereof
By designing chemiluminescent probe compounds, chemiluminescence is generated by using the oxidation reaction of TMAO in organic solvents, the problem of TMAO detection in the prior art is solved, and high sensitivity and high specificity detection is achieved Effect.
Patent Information
- Application Number
- CN202410882525.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-03
- Publication Date
- 2024-11-15
- Estimated Expiration
- 2044-07-03
AI Technical Summary
The detection of trimethylamine oxide (TMAO) in the prior art relies on the combination of liquid chromatography and mass spectrometry technology, requires high-end instruments and high technical requirements, has weak anti-interference ability of fluorescence quantitative technology, and the use of precious metal chemical reagents in electrochemiluminescence technology is expensive and exacerbated. Resource shortage.
A chemiluminescence probe compound was designed to form an ether bond by reacting with 1,3-dihalopropane and luminescent molecule phenolic hydroxyl groups, and oxidizing halo terminal methyl groups in organic solvents, resulting in β- Eliminate reactions and electron rearrangements to generate chemiluminescence, achieving high sensitivity and high specificity TMAO detection.
It realizes safe, accurate and effective TMAO detection, avoids the use of precious metals, improves the detection sensitivity and anti-interference ability, and has important application value.
Smart Images

Figure CN118955457A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the technical field of chemiluminescent probes, and more specifically, relates to a chemiluminescent probe compound and application thereof. Background Art
[0002] Trimethylamine oxide (TMAO) is an important small molecule compound with biological activity. TMAO in the human body can be ingested through food or synthesized in the body. Studies have shown that the intake of meat usually leads to an increase in the concentration of TMAO in the blood, which has been confirmed to be related to the microbial metabolism of choline and carnitine. TMAO can also enter the intestine and blood directly through dietary intake, such as eating marine foods with high TMAO content such as fish, shrimp, shellfish, etc. (such as Figure 1 At present, the scientific community generally believes that the long-term maintenance of high levels of TMAO in the circulatory system will lead to a series of diseases, including a variety of metabolic diseases, cardiovascular diseases, kidney diseases and inflammation. High levels of TMAO are also considered to be a disease marker associated with weakened stability of atherosclerotic plaques. The degree of correlation between TMAO and disease depends on the concentration of TMAO. Therefore, the development of TMAO detection methods to achieve accurate quantification is crucial for conducting TMAO-related research.
[0003] At present, the quantitative analysis of TMAO in biological samples mainly adopts liquid chromatography (LC) and LC combined with mass spectrometry (LC-MS / MS) (Yu Jie, Wang Dan, Gao Xiang, et al. Detection of trimethylamine oxide in fish oil and Antarctic krill oil by high performance liquid chromatography-mass spectrometry [J]. Journal of Food Safety and Quality, 2017, 8(02): 539-543. DOI: 10.19812 / j.cnki.jfsq11-5956 / ts.2017.02.032.). It is well known that for LC-based quantitative techniques, it is difficult to accurately quantify compounds with extremely small molecular weight and excellent water solubility (Cai, X.; Zou, L.; Dong, J.; Zhao, L.; Wang, Y.; Xu, Q.; Xue, X.; Zhang, X.; Liang, X., Analysis of highly polar metabolites in human plasma by ultra-performance hydrophilic interaction liquid chromatography coupled with quadrupole-time of flight mass spectrometry. Anal Chim Acta 2009, 650(1), 10-5.). TMAO has a molecular weight of 75.1 Daltons, carries a strong positive charge, has a water solubility of up to 793 g / L, does not contain a chromophore and is not easy to chemically label. It usually requires more advanced LC-MS / MS equipment for quantitative analysis, or requires the use of special chromatographic columns (Roverso, M.; Di Gangi, IM; Favaro, G.; Pastore, P.; Bogialli, S., Use of a Mixed Cationic-Reverse Phase Column for Analyzing Small Highly Polar Metabolic Markers in Biological Fluids for Multiclass LC-HRMS Method. Applied Sciences 2020, 10 (20), 7137.). LC-MS / MS analysis relies heavily on high-end instruments and has high technical requirements for analysts, making it difficult to use it as a common detection device for TMAO analysis.
[0004] In summary, it is urgent to develop a new detection method that is not dependent on liquid chromatography (LC) to achieve quantitative analysis of TMAO. In recent years, the academic community has turned its attention to the fluorescence analysis method of TMAO, and has established several fluorescence quantitative techniques. Although the fluorescence method has high sensitivity, biological molecules such as proteins are prone to fluorescence interference, and colored substances in biological samples are prone to fluorescence quenching. These reasons lead to weak anti-interference ability of fluorescence detection. Compared with fluorescence detection, chemiluminescence detection has significantly improved sensitivity and anti-interference ability. For example, Chinese patent application CN116465942A discloses a TMAO detection method based on electrochemiluminescence and its electrochemiluminescence sensor, which is specifically based on the electrochemiluminescence system of terpyridine ruthenium. By using trimethylamine generated by TMAO reduction as a co-reactant, the electrochemiluminescence reaction of trimethylamine and terpyridine ruthenium was used to successfully establish the relationship between TMAO and electrochemiluminescence signal intensity, and indirectly detect trimethylamine oxide. However, this method requires the use of chemical reagents containing precious metals, which are expensive and will aggravate the shortage of precious metal resources. In addition, the natural degradation products of TMAO such as trimethylamine will also interfere with the test. Summary of the invention
[0005] The technical problem to be solved by the present invention is to overcome the defects and shortcomings of the prior art that the determination of trimethylamine oxide mainly focuses on liquid chromatography and liquid chromatography-mass spectrometry technology, which relies heavily on high-end instruments and has high technical requirements for analysts; the fluorescence quantitative technology has weak anti-interference ability; the electrochemiluminescence technology requires the use of chemical reagents containing precious metals, which are expensive and will aggravate the problem of shortage of precious metal resources, and the natural degradation products of TMAO such as trimethylamine will also interfere with the test, and a chemiluminescent probe compound is provided.
[0006] The purpose of the present invention is to provide the application of the chemiluminescent probe compound.
[0007] Another object of the present invention is to provide a method for detecting trimethylamine oxide based on chemiluminescence.
[0008] The above-mentioned purpose of the present invention is achieved through the following technical solutions:
[0009] The present invention protects a chemiluminescent probe compound, wherein the chemiluminescent probe compound has a structure shown in formula (I):
[0010]
[0011] In the structure shown in formula (I), R is selected from iodine, bromine, fluorine or chlorine.
[0012] TMAO was used as an organic oxidant in the early stage, which can oxidize halogenated alkanes to form terminal aldehyde compounds. This oxidation is significantly enhanced in organic solvents (such as DMSO). The ether bond formed by the β position of aldehydes and ketones with hydroxyl groups is usually unstable. This type of structure can undergo a rapid spontaneous β-elimination reaction to release hydroxyl compounds. Based on the above considerations, the present invention designs the above-mentioned probe compound, which is based on a molecule that can emit green chemiluminescence. The molecule forms an ether bond by reacting 1,3-dihalopropane with the luminescent molecule phenolic hydroxyl group to obtain the corresponding probe compound.
[0013] Preferably, said R is selected from iodine or bromine.
[0014] More preferably, said R is selected from iodine.
[0015] The present invention protects the use of the chemiluminescent probe compound as a chemiluminescent probe.
[0016] The invention protects the application of the chemiluminescent probe compound in detecting trimethylamine oxide.
[0017] The present invention also protects a method for detecting trimethylamine oxide, wherein the method uses one or more of the chemiluminescent probe compounds as chemiluminescent probes to detect trimethylamine oxide.
[0018] Furthermore, the method specifically comprises the following steps:
[0019] S1. Prepare the sample solution to be tested;
[0020] S2. Mixing the organic solvent solution containing the blocking agent with the sample solution obtained in step S1, after fully blocking the interfering substances in the sample, adding the organic solvent solution containing the chemiluminescent probe compound thereto, mixing, fully reacting, recording the luminescence intensity, establishing a linear relationship between the luminescence intensity and the concentration of trimethylamine oxide, and obtaining the corresponding linear regression equation;
[0021] S3. The luminescence intensity of the sample solution obtained in step S1 is obtained through step S2, and is substituted into the linear regression equation obtained in step S2 to obtain the concentration of trimethylamine oxide in the sample.
[0022] The detection mechanism of the probe compound is that TMAO oxidizes the halogenated terminal methyl of the probe compound in an organic solvent such as DMSO to form an aldehyde group, which undergoes a β-elimination reaction to release a hydroxyl group. The intermediate causes the cleavage of the peroxide bridge through electron rearrangement to form an excited state intermediate. The energy of the intermediate is released in the form of photons to produce chemiluminescence.
[0023] Preferably, the blocking agent is o-phthalaldehyde and / or 2-cyano-6-methoxybenzothiazole. The purpose of adding the blocking agent is mainly to block interfering substances with nucleophilic effects, such as amino acids, etc. After blocking the interfering substances, the specificity of TMAO detection is improved.
[0024] Preferably, the organic solvent is one or more of dimethyl sulfoxide, acetonitrile, dimethylformamide, and dioxane. TMAO has good oxidation activity for halomethyl groups in organic solvents such as dimethyl sulfoxide (DMSO), acetonitrile (ACN), dimethylformamide (DMF), and dioxane.
[0025] More preferably, the organic solvent is dimethyl sulfoxide. Compared with the above-mentioned organic solvents, TMAO has the best oxidation activity for halomethyl groups in DMSO.
[0026] Furthermore, in step S2, the temperature for sufficient reaction is 25-50°C.
[0027] Furthermore, the sample solution to be tested is a biological sample solution, and the organisms include marine organisms and freshwater organisms, such as marine fish and shrimp or freshwater fish and shrimp.
[0028] Furthermore, the sample solution to be tested is extracted or further concentrated using conventional methods.
[0029] Compared with the prior art, the present invention has the following beneficial effects: the present invention makes full use of the unique chemical reactivity of TMAO to oxidize halogenated alkanes to form terminal aldehyde compounds, and constructs a new type of chemiluminescent probe compound with adamantane-dioxetane chemiluminescent skeleton, and the mechanism of the probe compound detecting TMAO is that TMAO oxidizes the halogenated terminal methyl of the probe compound in an organic solvent to form an aldehyde group, and the aldehyde group undergoes a β-elimination reaction to release a hydroxyl group, and the intermediate causes the cleavage of the peroxide bridge bond through electronic rearrangement, and the generated chemical energy is released in the form of chemiluminescence. The present invention is the first to establish a highly sensitive and specific TMAO detection method based on the probe compound, and the detection method is safe, accurate, effective, and simple, and has important application value. BRIEF DESCRIPTION OF THE DRAWINGS
[0030] Figure 1 Schematic diagram showing that increased plasma TMAO concentration is positively correlated with the occurrence and development of various diseases. TMAO can enter the human circulatory system through direct ingestion or biosynthesis. TMAO is difficult to quantify.
[0031] Figure 2 This is the H NMR spectrum of probe P1.
[0032] Figure 3This is the NMR carbon spectrum of probe P1.
[0033] Figure 4 This is the H NMR spectrum of probe P2.
[0034] Figure 5 This is the NMR carbon spectrum of probe P2.
[0035] Figure 6 Schematic diagram of realizing chemiluminescent detection of TMAO using the probe compound designed in the present invention.
[0036] Figure 7 (a) is a statistical graph of the kinetic curve of TMAO (50 μM) detection at different temperatures using probe P2 (100 μM); (b) is a statistical graph of the chemiluminescence kinetic curve when a fixed concentration of TMAO reacts with different concentrations of P1; (c) is a statistical graph of the chemiluminescence kinetic curve when a fixed concentration of TMAO reacts with different concentrations of P3.
[0037] Figure 8 (a) is a statistical diagram of the data for reducing the effect of amino acids on the detection reaction by adding OPA and CMBT; (b) is a statistical diagram of the data for selectivity and anti-interference test, where 1 represents alanine; 2 represents threonine; 3 represents histidine; 4 represents cysteine; 5 represents glutamic acid; 6 represents arginine; 7 represents lysine; 8 represents creatine; 9 represents homocysteine; 10 represents proline; 11 represents glycine; 12 represents serine; 13 represents aspartic acid; 14 represents creatinine; 15 represents urea; 16 represents iodinated acetylcholine; 17 represents trimethylamine (TMA); 18 represents H2O2; and 19 represents TMAO.
[0038] Fig. 9 This is a statistical graph of the chemiluminescence kinetic curve when P2 is used to detect different concentrations of TMAO.
[0039] Fig.10 (a) is a statistical graph of the detection curve of P2 chemiluminescence intensity compared with TMAO concentration recorded by a multifunctional microplate reader; (b) is a statistical graph of the linear correlation between chemiluminescence intensity and TMAO concentration recorded by a multifunctional microplate reader.
[0040] Fig.11 (a) is a statistical graph of the detection curve of P2 chemiluminescence intensity recorded by a handheld instrument compared with TMAO concentration; (b) is a statistical graph of the linear correlation between chemiluminescence intensity and TMAO concentration recorded by a handheld instrument.
[0041] Fig.12The chemiluminescence appearance of the probe P2 reacting with TMAO, wherein (a) is the appearance before the addition of TMAO; (b) is the appearance at 5 seconds after the addition of TMAO; and (c) is the appearance at 45 seconds after the addition of TMAO.
[0042] Fig.13 The data are statistical graphs of the TMAO content in the back muscle tissues of different fish and shrimps determined by the chemiluminescence analysis method based on the P2 probe, where (a) is the appearance of the tested fish and shrimp; (b) is a statistical graph of the chemiluminescence quantitative analysis results of the TMAO content in the back muscle tissues of four types of fish and shrimps. DETAILED DESCRIPTION
[0043] The present invention is further described below in conjunction with the accompanying drawings and specific examples, but the examples do not limit the present invention in any form. Unless otherwise specified, the reagents, methods and equipment used in the present invention are conventional reagents, methods and equipment in the art.
[0044] Unless otherwise specified, the reagents and materials used in the following examples are commercially available.
[0045] Example 1 Chemiluminescent probe compound and preparation method thereof
[0046] The synthetic route of the chemiluminescent probe compound is as follows:
[0047]
[0048] The specific preparation method comprises the following steps:
[0049] S1. Synthesis of compound 8: Compound 8 is a reported compound (Wang F, Wang Y, Zhang J, et al. Achemiluminescent probe for the real-time monitoring of esterases activities [J]. Sensors and Actuators B: Chemical, 2023, 375: 132880.), and was prepared by referring to the reported method to obtain a light yellow solid compound 8 with a total yield of 17% in 7 steps. 1H NMR (500MHz, CDCl3) δ7.96(d,J=16.1Hz,1H),7.39(d,J=8.0Hz,1H),6.87(d,J=7.9Hz,1H),6.62(d,J=16.1Hz,1 H),6.32(s,1H),3.83(s,3H),3.32(s,3H),3.28(t,J=3.1Hz,1H),2.13(t,J=3.3Hz,1H),1.99–1.63(m,12H).13C NMR (126MHz, CDCl3) δ167.69,150.63,139.43,139.20,136.58,132.90,126.76,123.66,12 1.95,121.52,119.73,57.36,51.81,37.06,32.91,29.74.HRMS(ESI):m / z[M+H]+calc.for C22H25ClO4H+:389.1514; found:389.1499.
[0050] S2. Synthesis of compound 9a: Compound 8 (200 mg, 0.52 mmol) was dissolved in 3 mL of N,N-dimethylformamide (DMF), 1,3-dibromopropane (158 mg, 0.78 mmol) and K2CO3 (86 mg, 0.62 mmol) were added, and the reaction was stirred at room temperature. After the reaction was completed by TLC monitoring, the mixture was diluted with ethyl acetate and washed 3 times with saturated brine. The organic layer was dried over anhydrous Na2SO4 and rotary evaporated under reduced pressure. The crude product was purified by silica gel column chromatography (n-hexane: ethyl acetate = 80:20) to obtain a yellow product 9a (241 mg, yield 91%). 1H NMR (500MHz, CDCl3) δ7.95(d,J=16.2Hz,1H),7.46(d,J=8.0Hz,1H),7.08(d,J=8.0Hz,1H),6.50(d,J=16.2Hz,1H),4.10( m,2H),3.83(s,3H),3.73(t,J=6.5Hz,2H),3.33(s,3H),3.28(s,1H),2.49-2.34(m,2H),2.08(s,1H),2.00-1.65(m,13H). 13 C NMR (126MHz, CDCl3) δ167.13,154.01,139.44,138.55,138.26,132.60,129.62,129.33,127.82,125.09,120.24,71.95, 57.33,51.88,39.23,39.09,38.67,37.09,33.29,32.97,31.54,30.17,29.77,29.75,28.39,28.23.HRMS(ESI):m / z[M+H] + calc.for C 25 H 30 BrClO4H + :511.1069; found 511.1066.
[0051] S3. Synthesis of compound 9b: Compound 8 (200 mg, 0.52 mmol) was dissolved in 3 mL of N,N-dimethylformamide (DMF), 1,3-diiodopropane (231 mg, 0.78 mmol) and K2CO3 (86 mg, 0.62 mmol) were added, and the reaction was stirred at room temperature. After the reaction was completed by TLC monitoring, the mixture was diluted with ethyl acetate and washed with saturated brine 3 times. The organic layer was dried over Na2SO4 and evaporated under reduced pressure. The crude product was purified by silica gel column chromatography (n-hexane: ethyl acetate = 80: 20) to obtain a yellow product 9b (223 mg, yield 77%). 1 H NMR(500MHz, CDCl3)δ7.95(m,1H),7.45(d,J=8.0Hz,1H),7.06(m,1H),6.50(m,1H),4.02(m,2H),3 .82(d,J=4.2Hz,3H),3.49(t,J=6.8Hz,2H),3.32(s,3H),3.27(s,1H),2.38(m,2H),1.79(m,13H). 13C NMR (126MHz, CDCl3) δ167.10,154.00,139.43,138.55,138.24,132.82,132.56,129.58,129.31,127.81,125.09,120 .25,73.88,57.32,51.90,39.22,39.07,38.65,37.08,34.09,32.96,29.73,28.38,28.22,2.10.HRMS(ESI):m / z[M+H] + calc.for C 25 H 30 IClO4H + :557.0950; found 557.0945.
[0052] S4. Synthesis of compound 10a (probe P1): The probe was prepared using a photoreactor capable of controlling the gas atmosphere. The specific preparation method comprises the following steps: Weigh compound 9a (100 mg, 0.2 mmol) obtained in step S2 and dissolve it in 5 mL of dichloromethane (DCM), and add a catalytic amount of methylene blue (0.02 mmol). Pass oxygen and irradiate with yellow light (590 nm, 12 W). After the reaction is completed by TLC monitoring, the reaction mixture is evaporated and concentrated under reduced pressure, and the crude product is purified by silica gel chromatography to obtain a yellow solid product P1 (91 mg, yield 84%). 1 H NMR (500MHz, CDCl3) δ7.95(m,2H),7.62(d,J=8.3Hz,1H),6.58(d,J=16.2Hz,1H),4.06(t,J=5.9Hz,2H),3.86(s,3H),3.7 6(t,J=6.5Hz,2H),3.25(s,3H),3.05(s,1H),2.49-2.39(m,2H),2.34(d,J=11.1Hz,1H),2.02(s,1H),1.94-1.25(m,11H). 13 C NMR (126MHz, CDCl3) δ166.85,154.49,137.98,135.26,131.20,128.96,127.56,125.33,121.55,111.72,96.36,7 1.97,51.97,49.74,36.61,33.91,33.62,33.16,32.64,32.24,31.57,29.67,26.19,25.84.HRMS(ESI):m / z[M+H] + calc.for C 25 H 30 BrClO6H+ :543.0697; found 543.0962. The H-NMR and C-NMR data of probe P1 can be found at Figures 2-3 .
[0053] S5. Synthesis of compound 10b (probe P2): The probe was prepared using a photoreactor that can control the gas atmosphere. The specific preparation method includes the following steps: Weigh the compound 9b (100 mg, 0.18 mmol) obtained in step S3 and dissolve it in 5 mL of dichloromethane (DCM), and add a catalytic amount of methylene blue (0.02 mmol). Pass oxygen and irradiate with yellow light (590 nm, 12 W). After the reaction is completed by TLC monitoring, the reaction mixture is evaporated and concentrated under reduced pressure, and the crude product is purified by silica gel chromatography to obtain a yellow solid product P2 (91.4 mg, yield 86%) 1 H NMR (500MHz, CDCl3) δ7.99-7.83(m,2H),7.59(d,J=8.3Hz,1H),6.54(m,1H),3.97(m,2H),3.83(s,3H) ,3.49(t,J=6.5Hz,2H),3.22(s,3H),3.02(s,1H),2.37(m,2H),2.31(d,J=12.3Hz,1H),1.70(m,12H). 13 C NMR (126MHz, CDCl3) δ166.85,154.49,138.01,135.25,131.20,128.97,127.54,125.33,121.56,111.73, 96.37,73.97,51.99,49.76,36.62,33.95,33.62,32.24,31.58,26.19,25.85,2.01.HRMS(ESI):m / z[M+H] + calc.for C 25 H 30 IClO6H + :588.9085; found 589.0840. The H-NMR and C-NMR data of probe P1 can be found at Figures 4-5 .
[0054] Example 2 Design of chemiluminescent probe compounds and their detection principle
[0055] TMAO was used as an organic oxidant in the early stage, which can oxidize halogenated alkanes to form terminal aldehyde compounds. This oxidation is significantly enhanced in organic solvents such as DMSO. However, the ether bond formed by the β position of aldehydes and ketones with hydroxyl groups is usually unstable. Such structures can undergo rapid spontaneous β-elimination reactions to release hydroxyl compounds. Based on the above considerations, the present invention designs the following Figure 6 The probe compound shown is based on a molecule that can emit green chemiluminescence. The molecule forms an ether bond through the reaction of 1,3-dihalopropane with the phenolic hydroxyl group of the luminescent molecule to obtain a corresponding probe compound having a chemiluminescent skeleton based on adamantane-dioxetane. The R group is Br, I, F or Cl. Since Br and I are better leaving groups and thus have a higher reaction rate, the R group is preferably Br or I. The detection mechanism of the probe compound is that TMAO oxidizes the halogenated terminal methyl of the probe compound in an organic solvent (such as DMSO) to form an aldehyde group, which undergoes a β-elimination reaction to release a hydroxyl group, and the intermediate causes the cleavage of the peroxide bridge through electron rearrangement to form an excited state intermediate, and the energy of the intermediate is released in the form of photons to produce chemiluminescence.
[0056] Example 3 Detection of TMAO at different temperatures and probe compound concentrations
[0057] (1) Effect of temperature on TMAO detection
[0058] 100 μL of DMSO solution containing 100 μM TMAO and 100 μL of DMSO solution containing 200 μM P2 were mixed and reacted at 28°C, 32°C, and 37°C, respectively. The luminescence kinetic curve data was recorded using a multifunctional microplate reader, and the temperature was controlled using the temperature setting function of the microplate reader. Each group of tests was repeated three times (n=3), and the results were averaged.
[0059] (2) Effect of P1 and P2 concentrations on TMAO detection
[0060] 100 μL of DMSO solution containing 100 μM TMAO and 100 μL of DMSO solution containing different concentrations of P1 or P2 were mixed and reacted at 37°C, and the luminescence kinetic curve was recorded using a multifunctional microplate reader. Each group of tests was repeated three times (n=3), and the results were averaged.
[0061] The results are as follows Figure 7 As shown in Figure (a), the present invention first uses probe P2 to detect TMAO at different temperatures (28, 32, 37°C), and the results show that increasing the temperature can significantly increase the reaction rate. One hour of reaction at 37°C can basically make the luminescence intensity close to the plateau phase, and the subsequent concentration test of the probe compound is tested at 37°C.
[0062] The probe concentration was further investigated, and the results showed that both P1 and P2 probes can be used for TMAO detection. The chemiluminescence intensity of the two detection systems increased with the increase of probe concentration. The probe concentration of 100 μM showed a relatively ideal reaction speed and luminescence intensity. A comprehensive comparison of P1 and P2 showed that when detecting the same concentration of TMAO, the P2 detection system had a higher luminescence intensity (see Figure 7 Figure (b) and Figure 7 This is due to the fact that iodine is a better leaving group than bromine. Therefore, subsequent tests were performed using P2 containing an iodine group.
[0063] Example 4 Optimization of TMAO detection conditions and construction of its quantitative analysis standard curve
[0064] For a 400 μL reaction system, 100 μL of DMSO solution containing TMAO and 100 μL of DMSO solution containing blocking agents OPA (4 mM) and CMBT (4 mM) were first mixed, and after standing at room temperature for 20 min, 200 μL of DMSO solution containing 200 μM P2 was added. The solution was reacted at 37°C for 60 min, and the luminescence intensity was recorded using a handheld chemiluminometer.
[0065] The P2 probe was used to optimize the detection conditions. The final concentration of TMAO in the test system was 50 μM, and the concentration of other potential interferents was 200 μM (when performing selectivity and anti-interference tests, the interferents and TMAO were co-dissolved in DMSO solution). The luminescence intensity was read using a handheld chemiluminescence detector, and the intensity was expressed as relative luminescence intensity RLU.
[0066] After preliminary screening, it was found that TMAO has good oxidation activity towards halogenated methyl groups in organic solvents such as dimethyl sulfoxide (DMSO), acetonitrile (ACN), dimethylformamide (DMF), and dioxane. Among them, TMAO has the best oxidation activity towards halogenated methyl groups in DMSO, so DMSO was used as the solvent for subsequent testing.
[0067] It was found in the experiment that high concentration of amino acids had a certain impact on the detection of TMAO. The present invention introduced two additives to block the impact of amino acids by screening. The blocking agent o-phthalaldehyde (OPA) is a widely used reagent that can block amino groups. 2-cyano-6-methoxybenzothiazole (CMBT) is also a reagent that has been reported to react quickly with cysteine. It can form a five-membered ring structure with Cys and simultaneously block amino groups and sulfhydryl groups (see Figure 8(a) in Figure 1). After using these two blocking agents to block potential nucleophilic interferences, the specificity of TMAO detection was improved. The selectivity and anti-interference test showed that even at a concentration 4 times that of TMAO, common interferences such as amino acids, trimethylamine, hydrogen peroxide, and creatinine had little effect on the chemiluminescence intensity. (See Figure 8 (b) in the figure). Therefore, the TMAO analysis method based on the P2 probe has high selectivity and anti-interference ability.
[0068] Furthermore, different concentrations of TMAO were detected using the P2 detection system, with a P2 working concentration of 100 μM and a detection temperature of 37°C. Fig. 9 As shown in the figure, the chemiluminescence intensity of P2 increases with the increase of TMAO concentration, and the luminescence intensity is obviously dependent on TMAO concentration. In addition, the time for the reaction to reach the luminescence plateau is also shortened with the increase of TMAO concentration.
[0069] use Fig. 9 The luminescence intensity at 60 minutes of reaction is plotted as the vertical axis and the TMAO concentration is plotted as the horizontal axis. Fig.10 It can be seen that the chemiluminescence intensity of P2 increases with the increase of TMAO concentration, but when TMAO is higher than 100μM, the luminescence intensity reaches a plateau. Fitting the detection curve found that when TMAO is between 5-50μM, there is an excellent linear correlation between the chemiluminescence intensity and the TMAO concentration (correlation coefficient R 2 =0.997). According to the formula of LOD=3σ / k, σ is the standard deviation of the blank group without TMAO for 3 times, and k is the slope of the fitting line. In the linear detection range of 5-50μM, the detection limit was calculated to be LOD=3.68nM.
[0070] Considering the convenience of on-site detection, the present invention further uses a handheld chemiluminescence instrument to draw a standard curve ( Fig.11 The trend of its luminescence intensity changing with TMAO is consistent with the results of the microplate reader. Curve fitting found that when TMAO is between 20-50 μM, there is a good linear correlation between the luminescence intensity and the TMAO concentration (R 2 =0.990). The test sensitivity of the small device is lower than that of the microplate reader, but it has the convenience of on-site detection.
[0071] Chemiluminescence detection can be quantitatively analyzed by multifunctional microplate reader, chemiluminescence detector, etc., and can also be qualitatively analyzed by simply taking a photo with a mobile phone or observing with the naked eye. To this end, the present invention incubates 3 mL of a DMSO solution containing P2 (1 mM) at 50°C for 5 minutes, then adds 300 μL of a DMSO solution of TMAO (1 mM) for imaging, and uses a mobile phone to shoot a luminescence video. Fig.12 The results show that chemiluminescence was stimulated immediately after the addition of TMAO, and then the luminescence gradually increased. At the 45th second after the addition of TMAO, the luminescence intensity was significantly higher than that at the 5th second. This fully demonstrates that the chemiluminescence analysis based on P2 can achieve convenient TMAO detection that is visible to the naked eye and can be recorded by mobile phones.
[0072] Example 5 Quantitative Analysis of TMAO in Marine or Freshwater Organisms
[0073] Previous studies have shown that marine fish usually contain higher concentrations of TMAO. TMAO is a very good protein stabilizer and osmotic pressure regulator, and plays an important role in helping marine fish adapt to high-salt and high-pressure environments. Studies have also shown that consuming marine fish can significantly increase the concentration of TMAO in the human circulatory system, but this dietary increase can quickly return to the initial level within a day. Whether TMAO directly ingested in the diet will have an impact on certain specific diseases remains controversial. Related research also relies heavily on accurate and rapid TMAO analysis methods.
[0074] In further research, the inventor team purchased four kinds of fish and shrimp from the market, among which Nemipterusvirgatus, Fenneropenaeus chinensis, and Siganus fuscescens are common marine fish and shrimp; freshwater cultured golden pomfret (Trachinotus ovatus) is a common edible fish that has been domesticated and adapted to freshwater environments. During the test, a small amount of the back muscle tissue (300-400 mg) of the above-selected marine or freshwater organisms was picked, and then the obtained muscle tissues were each immersed in 2 mL of acetonitrile (ACN). It is known that ACN has good solubility for TMAO, and it can precipitate proteins and other insoluble small molecules; tissue homogenate was obtained by tissue crusher, and then insoluble substances were removed by centrifugation (10000 rpm) for 5 min; the supernatant was taken, and the solvent was removed by air flow or reduced pressure evaporation to obtain an extract (solid) containing the above four biological tissues for TMAO quantitative analysis. The specific test method is as follows: for a 400 μL reaction system, 100 μL of DMSO solution containing TMAO (obtained by mixing the extracts of the four biological tissues obtained above with DMSO) and 100 μL of DMSO solution containing blocking agents OPA (4 mM) and CMBT (4 mM) were first mixed, and after standing at room temperature for 20 minutes, 200 μL of DMSO solution containing 200 μM P2 was added. The solution was reacted at 37°C for 60 minutes, and the luminescence intensity was recorded using a handheld chemiluminometer.
[0075] The results are as follows Fig.13 As shown, the TMAO content in the muscle of redfish was the highest among the tested fish and shrimp, reaching 831.40 mg / kg, followed by prawns (726.15 mg / kg) and mudfish (526.45 mg / kg). It is worth noting that the three fish and shrimp with higher content are all marine organisms. The TMAO content in the back muscle of the tested freshwater farmed golden pomfret was 210.65 mg / kg, which is significantly lower than that of marine fish. This also reflects the important role of TMAO in marine fish.
[0076] In order to verify the reliability of the method, the present invention carried out a spike recovery test. First, a specific concentration of TMAO was added to the redwood fish tissue extract with a known TMAO concentration, and then the spiked extract was quantitatively analyzed using the P2 probe method (same method as above), and the luminescence intensity was obtained by a handheld simple chemiluminometer. The recovery calculation was performed according to the recovery calculation formula, and the results are shown in Table 1. The recovery test showed that the spike recovery rate was between 0.88-1.04, and the average recovery rate was 0.96. For the quantitative analysis of compounds in environmental samples, the internationally recognized acceptable recovery rate is between 80-120%. Therefore, it can be said that the P2-based chemiluminescence analysis method can achieve sensitive and accurate quantitative analysis of TMAO in complex biological samples.
[0077] Table 1 TMAO spike recovery test based on probe P2
[0078]
[0079] Note: The TMAO spike recovery test was performed using the TMAO extract from the back muscle of redwood fish. The recovery rate was calculated as follows: (total amount measured after spike-measured content of the sample) / spiked amount.
[0080] The present invention makes full use of the unique chemical reactivity of TMAO to oxidize halogenated alkanes to form terminal aldehyde compounds, and constructs a new type of chemiluminescent probe. Among them, the P2 probe containing an iodine group has a high sensitivity for TMAO detection. Based on P2, a highly sensitive and highly specific TMAO detection method is established to achieve the determination of TMAO content in fish muscle tissue.
[0081] The above embodiments are preferred implementation modes of the present invention, but the implementation modes of the present invention are not limited to the above embodiments. Any other changes, modifications, substitutions, combinations, and simplifications that do not deviate from the spirit and principles of the present invention should be equivalent replacement methods and are included in the protection scope of the present invention.
Claims
1. A chemiluminescent probe compound, characterized in that The chemiluminescent probe compound has a structure shown in formula (I): In the structure shown in formula (I), R is selected from iodine, bromine, fluorine or chlorine.
2. The chemiluminescent probe compound according to claim 1, characterized in that The R is selected from iodine or bromine.
3. The chemiluminescent probe compound according to claim 2, characterized in that: The R is selected from iodine.
4. Use of the chemiluminescent probe compound according to any one of claims 1 to 3 as a chemiluminescent probe.
5. Use of the chemiluminescent probe compound according to any one of claims 1 to 3 in detecting trimethylamine oxide.
6. A method for detecting trimethylamine oxide, characterized in that: The method uses one or more of the chemiluminescent probe compounds described in any one of claims 1 to 3 as chemiluminescent probes to detect trimethylamine oxide.
7. The method according to claim 6, characterized in that: The method specifically comprises the following steps: S1. Prepare the sample solution to be tested; S2. Mixing the organic solvent solution containing the blocking agent with the sample solution obtained in step S1, after fully blocking the interferents in the sample, adding the organic solvent solution containing the chemiluminescent probe compound according to any one of claims 1 to 3 to the sample solution, mixing, fully reacting, recording the luminescence intensity, establishing a linear relationship between the luminescence intensity and the concentration of trimethylamine oxide, and obtaining the corresponding linear regression equation; S3. The luminescence intensity of the sample solution obtained in step S1 is obtained through step S2, and is substituted into the linear regression equation obtained in step S2 to obtain the concentration of trimethylamine oxide in the sample.
8. The method according to claim 7, characterized in that: The blocking agent is o-phthalaldehyde and / or 2-cyano-6-methoxybenzothiazole.
9. The method according to claim 7, characterized in that: The organic solvent is one or more of dimethyl sulfoxide, acetonitrile, dimethylformamide and dioxane.
10. The method according to claim 7, characterized in that: The sample solution to be tested is a biological sample solution.
Citation Information
Patent Citations
Trimethylamine oxide detection method based on electrochemical luminescence and electrochemical luminescence sensor thereof
CN116465942A
Diamondoid compounds
CN113840827A
Chemiluminescent probe and application thereof
CN115215833A
Chemiluminescent probe based on adamantene-1, 2-dioxetane as well as preparation method and application of chemiluminescent probe
CN116514767A
Spiro and dispiro 1,2,4-trioxolane antimalarials
US20080125441A1
